I don't think you'll find many that don't believe .40 is unobtainable. I think the $2.50 mark is attainable if the conference confirms the gene sequence passes to offspring. After this conference, I'm sure they will be discussing buyouts and partnerships with many interested companies, as KBLB has a great technology, but no real infrastructure as of yet to deploy it (that I know of).
Market Data 
Markets 
AI
